Insulin resistance, ADMA levels, and cardiovascular disease.
- 20 March 2002
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (11) , 1451-2
- https://doi.org/10.1001/jama.287.11.1451
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase InhibitorJAMA, 2002
- Prevalence of the Metabolic Syndrome Among US AdultsJAMA, 2002
- Risk of acute coronary events and serum concentration of asymmetrical dimethylarginineThe Lancet, 2001
- Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginineJournal of the American College of Cardiology, 2001
- An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytesJournal of the American College of Cardiology, 2000
- Does ADMA Cause Endothelial Dysfunction?Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
- LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial CellsCirculation Research, 2000
- Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjectsJournal of Internal Medicine, 1999
- Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolaseBritish Journal of Pharmacology, 1996
- The Role of Endothelium in Cardiovascular Homeostasis and DiseasesJournal of Cardiovascular Pharmacology, 1993